JAMA Editor in Chief Kirsten Bibbins-Domingo reviews 4 JAMA trials presented at this year’s European Society of Cardiology (ESC) Congress on antihypertensive continuation before elective surgery, potassium supplementation after cardiac surgery, pulmonary vein isolation for symptomatic atrial fibrillation, and a triple-drug combination pill for resistant hypertension in Africa.

Related Content:

Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria
Is a Low-Dose Triple-Drug Combination Pill Protocol the Answer for Hypertension Control in Sub-Saharan Africa?
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery
Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation

JAMA Highlights From ESC 2024

JAMA Clinical Reviews